Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | GABRP | O00591 | 4/20 | 0.48 |
| ▸ | GABRD | O14764 | 4/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.48 |
| ▸ | GABRE | P78334 | 4/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.48 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.48 |
| ▸ | GABRQ | Q9UN88 | 4/20 | 0.48 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9406859 | 1.00 | ALDH1A1 (0.62) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL12474237 | 1.00 | ALDH1A1 (0.62) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL28858092 | 1.00 | ALDH1A1 (0.62) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL8817349 | 1.00 | — | — | |
| Acetic Acid SCHEMBL6150069 | 1.00 | ALDH1A1 (0.62) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL21227 | 1.00 | ALDH1A1 (0.62) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL11456315 | 0.97 | ALDH1A1 (0.59) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL9486803 | 0.97 | ALDH1A1 (0.59) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL10622613 | 0.97 | ALDH1A1 (0.59) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| Acetic Acid SCHEMBL9615697 | 0.97 | ALDH1A1 (0.59) | ALDH1A1GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110804022-B | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-110804022-A | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2020-02-18 | — | — | CN | claimed |
| US-5618936-A | CYCLIZATION OF 1,2-DIAMINOPROPANE TETRAACETIC ACID OR SODIUM SALT | SICOR SPA (IT) | 1997-04-08 | — | — | US | claimed |
| CN-114685383-B | Preparation method of dexrazoxane | 四川汇宇制药股份有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-113636980-B | Preparation method of dexrazoxane | 北京泰德制药股份有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-110804022-B | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-110804022-B | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114685383-A | Preparation method of dexrazoxane | 四川汇宇制药股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-113636980-A | Preparation method of dexrazoxane | 北京泰德制药股份有限公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-110804022-A | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2020-02-18 | — | — | CN | disclosed |
| CN-110804022-A | Preparation method of dexrazoxane | 扬子江药业集团有限公司 | 2020-02-18 | — | — | CN | disclosed |
| US-8455641-B2 | Method for producing 4,4′-(propane-1,2-diyl)-dipiperazine-2,6-dione | CYATHUS EXQUIRERE PHARMAFORSCHUNGS GMBH (AT) | 2013-06-04 | — | — | US | disclosed |
| WO-2012081036-A2 | A PROCESS FOR PREPARATION OF 4,4'-(1-METHYL-1,2-ETHANDIYL)-BIS-(2,6-PIPERAZINEDIONE) | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-06-21 | — | — | WO | disclosed |
| US-20100152447-A1 | Novel Method for Producing 4,4-(1-Methyl-1,2-Ethanediyl)-BIS-(2,6-Piperazinedione) | CYATHUS EXQUIRERE PHARMAFORSCHUNGS GMBH (AT) | 2010-06-17 | — | — | US | disclosed |
| WO-1992000740-A2 | BIS-DIOXOPIPERAZINES AND THEIR USE AS PROTECTION AGENTS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1992-01-23 | — | — | WO | disclosed |
| US-4963679-A | Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes | ERBAMONT, INC. (US) | 1990-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152447-A1 | Novel Method for Producing 4,4-(1-Methyl-1,2-Ethanediyl)-BIS-(2,6-Piperazinedione) | CPS1, ABAT, ALDH7A1 | ALDH1A1 184/4885GABRP 628/4885GABRD 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.